Bedaquiline Fumarate
Bedaquiline Fumarate is an anti-tuberculosis API used in the management of drug-resistant tuberculosis as part of combination therapy.
Detailed technical, regulatory, and supply information is available for commercial evaluation.
Technical Overview
Bedaquiline Fumarate – CAS 845533-86-0
CAS Number
845533-86-0
Category
Anti-infective
Therapeutic Class
Anti-tuberculosis agent
Description
Bedaquiline Fumarate is an anti-tuberculosis API used in the management of drug-resistant tuberculosis as part of combination therapy.
Applications
- Drug-resistant tuberculosis (as part of combination therapy)
Handling & Supply Details
Packaging
Standard export packaging in double-lined HDPE drums or fiber drums with inner poly liners; custom pack sizes available on request.
Product Inquiry
Disclaimer
Products offered are intended strictly for R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer.